Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.

Source:http://linkedlifedata.com/resource/pubmed/id/20462915

Download in:

View as

General Info

PMID
20462915